Thus our findings have uncovered a new role of galectin-1 in promoting the chemoresistance in hepatocellular carcinoma, and so represent a promising approach to vanquish the chemoresistance acquired towards the cisplatin treatment. Here, LGALS1 is linked to hepatocellular carcinoma.